Publications by authors named "Yulia N Demchenko"

Claim this Profile
T
Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma.
Seth J Welsh, Benjamin G Barwick, Erin W Meermeier, Daniel L Riggs, Chang-Xin Shi, Yulia N Demchenko

Blood Cancer Discov· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma.
Maurizio Affer, Marta Chesi, Wei-Dong G Chen, Jonathan J Keats, Yulia N Demchenko

Leukemia· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complex IGH rearrangements in multiple myeloma: Frequent detection discrepancies among three different probe sets.
Gina Y Kim, Ana Gabrea, Yulia N Demchenko, Leif Bergsagel, Anna V Roschke

Genes Chromosomes Cancer· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel inhibitors are cytotoxic for myeloma cells with NFkB inducing kinase-dependent activation of NFkB.
Yulia N Demchenko, Leslie A Brents, Zhihong Li, Leif P Bergsagel, Lawrence R McGee

Oncotarget· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A critical role for the NFkB pathway in multiple myeloma.
Yulia N Demchenko, W Michael Kuehl

Oncotarget· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classical and/or alternative NF-kappaB pathway activation in multiple myeloma.
Yulia N Demchenko, Oleg K Glebov, Adriana Zingone, Jonathan J Keats, P Leif Bergsagel

Blood· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis